| P2093 | author name string | Amresh Shrivastava | |
| | Nilesh Shah | |
| | Gurvinder Kalra | |
| | Sanjay Kukreja | |
| P2860 | cites work | Polypharmacy in psychiatric practice in the Canary Islands | Q24791813 |
| | Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist | Q30981017 |
| | Qualitative insights into general practitioners views on polypharmacy | Q33692513 |
| | Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study | Q33972014 |
| | Strategies for monitoring outcomes in patients with bipolar disorder | Q33985405 |
| | Rational antipsychotic polypharmacy | Q34067923 |
| | National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 |
| | National Trends in Child and Adolescent Psychotropic Polypharmacy in Office-Based Practice, 1996-2007 | Q34187891 |
| | Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription. | Q34447495 |
| | The case against "the evidence": a different perspective on evidence-based medicine | Q34482310 |
| | The use of drug monotherapy in psychiatric inpatient treatment | Q34630953 |
| | National trends in psychotherapy by office-based psychiatrists | Q34804065 |
| | Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations | Q34941330 |
| | Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review | Q35067871 |
| | A study of an antipsychotic prescription pattern of patients with schizophrenia in a developing country | Q35109558 |
| | Personalized medicine in psychiatry: ethical challenges and opportunities. | Q35237132 |
| | Treatment-resistant Schizophrenia: Evidence-based Strategies | Q35964353 |
| | Clinicians' reasons for antipsychotic coprescribing. | Q36005087 |
| | Reducing polypharmacy through the introduction of a treatment algorithm: use of a treatment algorithm on the impact on polypharmacy. | Q36562809 |
| | A mixed method study of the merits of e-prescribing drug alerts in primary care | Q36608251 |
| | Appropriate prescribing in elderly people: how well can it be measured and optimised? | Q36880974 |
| | Psychiatric polypharmacy: a clinical approach based on etiology and differential diagnosis | Q38003490 |
| | LICAVAL: combination therapy in acute and maintenance treatment of bipolar disorder | Q38372418 |
| | Seven alternatives to evidence based medicine | Q38641221 |
| | Influence of antipsychotic agents on heart rate variability in male WKY rats: implications for cardiovascular safety | Q39609390 |
| | Anti-psychotic drug prescription pattern for schizophrenia: Observation from a general hospital psychiatry unit | Q41564243 |
| | Polypharmacy and medication adherence: small steps on a long road | Q42347505 |
| | Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia | Q42380356 |
| | Reducing antipsychotic polypharmacy among psychogeriatric and adult patients with chronic schizophrenia | Q42835527 |
| | Psychopharmacology: rational and irrational polypharmacy | Q43463430 |
| | Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution | Q43626934 |
| | Prescription drug use, diagnoses, and healthcare utilization among the elderly | Q44332153 |
| | Polypharmacy in patients with schizophrenia. | Q44662777 |
| | Polypharmacy: a case report and new protocol for management | Q45110767 |
| | Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial | Q46237668 |
| | Clinical practice variations in prescribing antipsychotics for patients with schizophrenia | Q47669683 |
| | Exploring regional variation in antipsychotic coprescribing practice: a Danish questionnaire survey. | Q50552283 |
| | The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards - a cluster randomized controlled trial. | Q50889035 |
| | Combination antipsychotic therapy in clinical practice. | Q51951314 |
| | Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study | Q58813233 |
| | [Factors associated with chronic drug consumption in the elderly] | Q73658983 |
| | Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study | Q74369393 |
| | Antipsychotic polypharmacy: squandering precious resources? | Q77716637 |
| | Antipsychotic polypharmacy: evidence based or eminence based? | Q78336049 |
| | Use of medications and polypharmacy are increasing among the elderly | Q78385165 |
| | Polypharmacy: when is it rational? | Q80112030 |
| | [Influence of income on the association between cognitive impairment and polypharmacy: Bambuí Project] | Q80504352 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 82-99 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Mens Sana Monographs | Q6817333 |
| P1476 | title | Polypharmacy in psychiatry: a review | |
| P478 | volume | 11 | |